Global Cryostat Microbiome Equipment Market - 2022-2029

Global Cryostat Microbiome Equipment Market - 2022-2029
Market Overview

Cryostat Microbiome Equipment Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

The cryostat microbiome equipment is a specialized precision cutting tool that can frequently and reliably slices sections from a block of implanted tissue at extremely low temperatures (between -20°C and -30°C). The cryostat microbiome apparatus uses a cooling chamber for the cryofixation of the tissues necessary for quick and precise slicing. For tissue histopathology, the equipment is mostly employed in diagnostic and research laboratories.

Market Dynamics

Increasing awareness regarding early cancer diagnosis is expected to drive market growth.

The rising incidence of cancer cases and the accompanying treatments call for the use of cryostat microbiome equipment to diagnose the contaminated tissues. For instance, the accuracy and results of biopsy by frozen sections for clinical non-melanoma skin cancer are examined in a report titled Diagnostic Biopsy via In-Office Frozen Sections for Clinical Nonmelanoma Skin Cancer. The study found that the in-office biopsy using frozen sections was extremely accurate in identifying skin cancer cells that weren't melanoma. The approach might aid in hastening disease detection and treatment, improving results and patient satisfaction. Therefore, it is expected that growing research into diagnosing and treating cancer cases utilizing cryostat microbiome equipment would drive the market in the forecast period.

Restraint

The high cost associated with the cryostat microbiome equipment and the lack of skilled professionals to operate cryostat microbiome equipment are the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The cryostat microbiome equipment market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. All outpatient treatments were postponed or limited during the COVID-19 pandemic because most chronic therapies were seen as non-urgent to reduce the risk of viral transmission. For the study of tissue histopathology, cryostat microtome equipment is frequently employed in diagnostic and research laboratories. In addition, as the pandemic spread, the market for cryostat microtome equipment has benefited from an increased study into the immunohistochemistry of COVID-19-infected tissues. In contrast, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Automatic cryostat microtome equipment segment is expected to hold the largest market share in cryostat microbiome equipment market

The automatic cryostat microtome equipment segment is expected to dominate in 2021. The segment benefits because tissue sectioning automation can provide labs with faster setup and alignment, programmable settings, speedier sectioning, and motorized trimming. This makes it possible for histopathologists to process more sample blocks in a shorter time, leading to faster patient diagnosis. Saving time allows for processing more samples and making use of pathologists' output by allowing them to work on different aspects of tissue processing simultaneously. Moreover, Automated microtomes can also be used for quality assurance. Engineers and producers know the impact human error and weariness can have on the quality of produced portions. The motorized feed can produce the same velocity each time to cut continuous sections of the same quality for thicker sections and harder specimens, including malignant tissue, calcified tissue, and decalcified teeth. For instance, An innovative, precise specimen feeding mechanism called the Minux Rotary Paraffin Microtomes (Semi-Auto / Fully Auto) perfectly enables microtomists to get outstanding, thin serial section results. A patented visible pointer helps you position sections quickly and precisely. It is frequently employed in anatomical pathology and histopathology. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global cryostat microbiome equipment market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of Cancer, technological advancements in immunohistochemistry research studies, and increasing adoption of highly advanced techniques in the cryostat microbiome equipment, product launches and acquisitions by the key market players are some of the factors the market is expected to boost in the forecast period. For instance, according to the American Cancer Society, in 2020, an estimated 1.8 million new cancer cases and 606,520 cancer deaths in the United States will be diagnosed. In contrast, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Therefore, it has increased the adoption of cryostat microbiome equipment. Moreover, Precisionary Instruments LLC announced the release of a new Precision Cryostat in April 2020. (Model CF-6100). In pathology, dermatology, and histology labs, the CF-6100 cryostat is a high-precision microtome with dual compressors, UV light disinfection, and an LED touchscreen control panel that encourages and supports high-quality tissue sectioning. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the cryostat microbiome equipment market are Epredia, Histo-Line Laboratories S.R.L., Leica Microsystems Nussloch GmbH, Sakura Finetek USA, Slee Medical GmbH, Labotronics Scientific Ltd., Bright Instrument Co Limited, Spencers World, Shenyang Roundfin Trade Co., Ltd., Jinhua YIDI Medical Appliance CO.,LTD.

Epredia:

Overview:

Epredia is a leader in anatomical pathology and offers various options for accurate cancer diagnosis. It was created in July 2019 due to PHC Group purchasing Thermo Fisher Scientific. The business's line of products, which also includes morgue and autopsy tools, cytology fixatives, cytology staining and centrifuges, slide stainers, adhesion slides, micro slides, beveled micro slides, and cassette printers, enables the healthcare sector to bring much-needed standardization to non-standardized patient testing settings. Additionally, it is powered by reputable companies like Richard-Allan Scientific, Microm, Menzel Gläser, and Shandon.

Product Portfolio:

Cryostar NX70 Cryostat: The Thermo Cryostar NX70 Cryostat features digital control, an ergonomic design, and built-in cleaning procedures. This cryostat has rapid reaction temperature control for temperature maintenance during a high-volume session. Programmable temperatures range from -50° to +10°C, and a temperature-controlled knife is kept at -35° to -5°C. This cryostat has full-color touch screen and joystick navigation as its innovative control system. Users can programme their favourites, three presets for frequently used parameters, and their preferred temperature settings and section thicknesses from this control panel. The sectioning thickness range is 0.5-500 m, and the fine range is in graduated steps from 0.5 to 100 m.

The global cryostat microbiome equipment market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.